Amyloid-beta PET utility in Alzheimer’s desease / Symposium CANM Annual Conference 2022

Поділитися
Вставка
  • Опубліковано 18 вер 2024
  • Symposium CANM (Canadian Association of Nuclear Medecine) Annual Conference 2022
    1st October 2022
    Speaker : Nazanin Mirzaei Ph.D
    Amyloid-beta PET utility on Alzheimer’s desease Neuraceq ® (florbetaben F18 injection)
    LMI approved imaging agent for diagnosis of Alzheimer’s desease

КОМЕНТАРІ •